Prof. Mia Horowitz
Mia Horowitz graduated from the department of Genetics, The Weizmann Institute of Science, Rehovot Israel, in 1980. Following a two and half years as a post-doctoral fellow under the supervision of Prof. P. A. Sharp at MIT, Massachusetts, USA, she joined the Weizmann institute as an investigator. She initiated a project aiming at understanding the molecular biology underlying Gaucher disease in 1985. In 1990 she moved to Tel Aviv University and in 1998 became a full professor. She served as department head between 1999-2003.
Prof. Ari Zimran
Professor Ari Zimran
is Director of the Gaucher Clinic at Shaare Zedek Medical Center in Jerusalem, Israel. This is the world’s largest referral center for Gaucher disease, where more than 750 patients are followed and about 350 patients are treated with enzyme replacement therapy. Professor Zimran developed his interest in Gaucher disease during his fellowship at the Scripps Research Institute, Department of Molecular and Experimental Medicine, in La Jolla, California, USA under the mentorship of Professor Ernest Beutler.
Professor Zimran has published more than 290 professional papers and reviews, and has edited three books; he has been a leader in clinical trials for new treatments for Gaucher disease, including Cerezyme, Zavesca, VPRIV and Elelyso.